Linda Palczuk

This profile gathers the share dealings of Linda Palczuk in Avadel Pharmaceuticals PLC, where the filings describe the role as board member. Over a trading history stretching from 27 May 2022 to 12 February 2026, the count stands at 9 filings.

No open-market sale appears; the market trades are 5 purchases worth €129k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants.

In size, the median ticket on the buying side is €29k. On 4 out of 5 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 12 February 2026, the filings show a transaction worth €1.4M in Avadel Pharmaceuticals PLC. The most recent open-market purchase was published on 22 January 2025, 634 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.